|
|
| Year : 2017 | Volume
: 9
| Issue : 3 | Page : 125 |
|
| Cutaneous larva migrans |
|
|
Richie Manikat1, Saman Kannangara2
1 Department of Internal Medicine, Easton Hospital, Easton, PA 18042, USA
2 Valley Infectious Disease Specialists Ltd, Chief, Division of Infectious Diseases, Easton Hospital, Easton, PA 18042, USA
Click here for correspondence address and email
| Date of Web Publication | 9-Aug-2017 |
|
|
 |
|
How to cite this article:
Manikat R, Kannangara S. Cutaneous larva migrans. J Global Infect Dis 2017;9:125 |
Sir,
Cutaneous larva migrans is a characteristic serpiginous skin lesion which may be seen in travelers. The most common causative organisms are Ancylostoma braziliense and Ancylostoma caninum.[1]
A 49 year-old male presented to the office complaining of a rash on his legs. The patient had recently spent 5 days in Florida moving lemon trees. Five days after returning to his home in eastern Pennsylvania, the patient noticed a rash on both legs. Examination showed multiple red, raised, serpiginous lesions on his lower legs [Figure 1]. The patient was started on ivermectin orally for 2 days. He was reevaluated after 3 weeks. The rash had improved significantly, the serpiginous lesions were fading, and pruritus had disappeared [Figure 2].
Cutaneous larva migrans is most commonly associated with animal hookworms. The infection is frequently seen in the Southeastern United States. The diagnosis is clinical. Antihelminthic therapy with ivermectin or albendazole is frequently curative.[2]
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
 References | |  |
| 1. | Baple K, Clayton J. Hookworm-related cutaneous larva migrans acquired in the UK. BMJ Case Rep 2015;2015. pii: bcr2015210165.  |
| 2. | Veraldi S, Bottini S, Rizzitelli G, Persico MC. One-week therapy with oral albendazole in hookworm-related cutaneous larva migrans: A retrospective study on 78 patients. J Dermatolog Treat 2012;23:189-91. [ PUBMED] |
Correspondence Address:
Richie Manikat
Department of Internal Medicine, Easton Hospital, 250 S 21st St., Easton, PA 18042
USA
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/jgid.jgid_171_16
[Figure 1], [Figure 2] |
|
|
|
|
|
|
|
|
|
